Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity

Código QR

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity

Raul Velez-Montoya1, Carmen Clapp2, Jose Carlos Rivera2, Gerardo Garcia-Aguirre1, Virgilio Morales-Cant&oacute;n1, Jans Fromow-Guerra1, Jose Luis Guerrero-Naranjo1, Hugo Quiroz-Mercado31Retina Department Asociaci&oacute;n para Evitar la Ceguera en M&eacute;xico IAP, M&amp...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Raul Velez-Montoya, Carmen Clapp, Jose Carlos Rivera, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/1164358f389747d0bea7c10b6a09ce59
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between assisted reproductive technology and advanced retinopathy of prematurity
por: RV Paul Chan, et al.
Publicado: (2010)

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy
por: Bahariv, et al.
Publicado: (2012)

Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovascular proliferation
por: Takaki Kobayashi, et al.
Publicado: (2010)

Prevalence of retinopathy of prematurity in Latin America
por: Carrion JZ, et al.
Publicado: (2011)

Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
por: Sankarathi Balaiya, et al.
Publicado: (2011)

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata S, et al.
Publicado: (2019)

Multiple pregnancies and its relationship with the development of retinopathy of prematurity (ROP)
por: Fiorot CA, et al.
Publicado: (2011)

A case of retinopathy of prematurity treated by pattern scan laser photocoagulation
por: Ota S, et al.
Publicado: (2014)

The role of serum apelin in retinopathy of prematurity
por: Ali YF, et al.
Publicado: (2017)

Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
por: Lin CJ, et al.
Publicado: (2016)

Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity
por: Arámbulo O, et al.
Publicado: (2015)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin HS, et al.
Publicado: (2020)

Refractive outcome of prethreshold retinopathy of prematurity treated by diode laser: follow-up at 5 years
por: Nguyen PH, et al.
Publicado: (2015)

Structural and functional results of indirect diode laser treatment for retinopathy of prematurity from 1999 to 2003 in Kuwait
por: Wani VB, et al.
Publicado: (2013)

Retinopathy of Prematurity and Assisted Reproductive Technology: Is There an Association?
por: Alsammahi A, et al.
Publicado: (2021)

High risk factors of retinopathy of prematurity
por: Zuo-Wei Li, et al.
Publicado: (2021)

Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients
por: Farhood QK, et al.
Publicado: (2014)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Majid Abrishami, et al.
Publicado: (2021)

Incidence and Risk Factors Associated with Retinopathy of Prematurity in Peru
por: Carranza-Mendizabal CS, et al.
Publicado: (2021)

Efficacy of WINROP as a Screening Tool for Retinopathy of Prematurity in the East Coast of Malaysia
por: Lim ZD, et al.
Publicado: (2020)

Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
por: Ji MH, et al.
Publicado: (2020)

Opacification of hydrophilic intraocular lenses after Descemet stripping automated endothelial keratoplasty
por: Morgan-Warren PJ, et al.
Publicado: (2015)

Outcomes of Pre-Early Treatment for Retinopathy of Prematurity (Pre-ETROP)
por: Titawattanakul Y, et al.
Publicado: (2020)

Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
por: Fujikawa M, et al.
Publicado: (2013)

Correlation between risk factors during the neonatal period and appearance of retinopathy of prematurity in preterm infants in neonatal intensive care units in Alexandria, Egypt
por: Abdel Hadi AM, et al.
Publicado: (2013)

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
por: Kiss S, et al.
Publicado: (2014)

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
por: Fouzdar Jain S, et al.
Publicado: (2018)

Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
por: Abdel Salam Gomaa N, et al.
Publicado: (2021)

Assessment of Diabetic Retinopathy Vascular Density Maps
por: Saif PS, et al.
Publicado: (2020)

Paraneoplastic retinopathy associated with retroperitoneal liposarcoma
por: Mineo Kondo, et al.
Publicado: (2010)

Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study
por: Gezmu AM, et al.
Publicado: (2020)

Endothelial distance after phakic iris-fixated intraocular lens implantation: a new safety reference
por: Ferreira TB, et al.
Publicado: (2014)

In vivo characterization of ischemic retina in diabetic retinopathy
por: Lukas Reznicek, et al.
Publicado: (2010)

Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration
por: Kano M, et al.
Publicado: (2015)

Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients
por: Isola V, et al.
Publicado: (2013)

Analyses of ERG in a patient with intraocular lymphoma
por: Chieko Yasuda, et al.
Publicado: (2010)

Diffractive multifocal intraocular lens interferes with intraoperative view
por: Mami Yoshino, et al.
Publicado: (2010)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão M, et al.
Publicado: (2017)

Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
por: Jimmy S. Chen, MD, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan CS, et al.
Publicado: (2017)